Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_4
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
3(75.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 43 (75.0%)
N/A1 (25.0%)

Trials by Status

unknown125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
unknownnot_applicable

A Randomized Controlled Trial to Investigate The Role of Adjuvant Inhalable Sodium Bicarbonate Solution 8.4% in Treatment of COVID-19

NCT05035524
completedphase_4

Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease

NCT02476526
completedphase_4

Early Hydration in Acute Myocardial Infarction

NCT01742130
completedphase_4

Hydration and Contrast-Induced Nephropathy in Primary Angioplasty

NCT00770614

Clinical Trials (4)

Showing 4 of 4 trials
NCT05035524Not Applicable

A Randomized Controlled Trial to Investigate The Role of Adjuvant Inhalable Sodium Bicarbonate Solution 8.4% in Treatment of COVID-19

Unknown
NCT02476526Phase 4

Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease

Completed
NCT01742130Phase 4

Early Hydration in Acute Myocardial Infarction

Completed
NCT00770614Phase 4

Hydration and Contrast-Induced Nephropathy in Primary Angioplasty

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4